Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy.

Stephan, Carsten; Ralla, Bernhard; Bonn, Florian; Diesner, Max; Lein, Michael; Jung, Klaus

Stephan, Carsten; Ralla, Bernhard; Bonn, Florian; Diesner, Max; Lein, Michael; Jung, Klaus.

Afiliación

Stephan C; Department of Urology, Charité-Universitätsmedizin Berlin, 10115 Berlin, Germany.
Ralla B; Berlin Institute for Urologic Research, 10115 Berlin, Germany.
Bonn F; Department of Urology, Charité-Universitätsmedizin Berlin, 10115 Berlin, Germany.
Diesner M; Immundiagnostik AG, 64625 Bensheim, Germany.
Lein M; Immundiagnostik AG, 64625 Bensheim, Germany.
Jung K; Department of Urology, Sana Medical Center Offenbach, 63069 Offenbach am Main, Germany.

Cancers (Basel) ; 14(6)2022 Mar 18.

Article en En | MEDLINE | ID: mdl-35326710

Palabras clave

1,25(OH)2D3; 24,25(OH)2D3; 25(OH)D3; circulating vitamin D metabolites; prostate cancer; prostatectomy; vitamin D; zoledronic acid treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google